Three-dimensional domain architecture of the ADAM family proteinases

Seminars in Cell and Developmental Biology

Volumn 20, Issue 2, 2009, Pages 146-152

  Takeda, Soichi ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

ADAM; ADAMTS; Disintegrin metalloproteinases; Ectodomain shedding; MDC proteins

Indexed keywords

ADAM PROTEIN; CELL SURFACE PROTEIN; COLLAGEN TYPE 1; COLLAGEN TYPE 12; COLLAGEN TYPE 14; CYSTEINE; CYTOKINE; CYTOKINE RECEPTOR; DISINTEGRIN; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; MATRILISIN 1; MEMBRANE PROTEIN; METALLOPROTEINASE; PROTEIN ADAM10; PROTEIN ADAM12; PROTEIN ADAM17; PROTEIN ADAM19; PROTEIN ADAM28; PROTEIN ADAM9; PROTEIN ADAMTS; PROTEIN ADAMTS1; PROTEIN ADAMTS4; PROTEIN ADAMTS5; PROTEINASE; SHEDDASE; SNAKE VENOM METALLOPROTEINASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CELL INTERACTION; CRYSTAL STRUCTURE; ENZYME SUBSTRATE COMPLEX; MOLECULAR RECOGNITION; PHYLOGENY; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; X RAY CRYSTALLOGRAPHY;

MAMMALIA;

EID: 63649149047     PISSN: 10849521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcdb.2008.07.009     Document Type: Review

References (53)

1. White J.M., Bidges L., DeSimone D.W., Tomczuk M., and Wolfsberg T.G. Introduction to the ADAM family. In: Hooper N.M., and Lendeckel U. (Eds). The ADAM Family of Proteinases (2005), Springer, Dordrecht, The Netherlands 1-29
2. Seals D.F., and Courtneidge S.A. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev 17 1 (2003) 7-30
3. Becherer J.D., and Blobel C.P. Biochemical properties and functions of membrane-anchored metalloprotease-disintegrin proteins (ADAMs). Curr Top Dev Biol 54 (2003) 101-123
4. Moss M.L., Jin S.L., Milla M.E., Bickett D.M., Burkhart W., Carter H.L., et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385 6618 (1997) 733-736
5. Black R.A., Rauch C.T., Kozlosky C.J., Peschon J.J., Slack J.L., Wolfson M.F., et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385 6618 (1997) 729-733
6. Blobel C.P. ADAMs: key components in EGFR signalling and development. Nat Rev Mol Cell Biol 6 1 (2005) 32-43
7. Prenzel N., Zwick E., Daub H., Leserer M., Abraham R., Wallasch C., et al. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402 6764 (1999) 884-888
8. Peschon J.J., Slack J.L., Reddy P., Stocking K.L., Sunnarborg S.W., Lee D.C., et al. An essential role for ectodomain shedding in mammalian development. Science 282 5392 (1998) 1281-1284
9. Moss M.L., and Bartsch J.W. Therapeutic benefits from targeting of ADAM family members. Biochemistry 43 23 (2004) 7227-7235
10. Duffy M.J., Lynn D.J., Lloyd A.T., and O'Shea C.M. The ADAMs family of proteins: from basic studies to potential clinical applications. Thromb Haemost 89 4 (2003) 622-631
11. Mochizuki S., and Okada Y. ADAMs in cancer cell proliferation and progression. Cancer Sci 98 5 (2007) 621-628
12. Gomis-Ruth F.X. Structural aspects of the metzincin clan of metalloendopeptidases. Mol Biotechnol 24 2 (2003) 157-202
13. Bode W., Gomis-Ruth F.X., and Stockler W. Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the 'metzincins'. FEBS Lett 331 1-2 (1993) 134-140
14. Kuno K., Kanada N., Nakashima E., Fujiki F., Ichimura F., and Matsushima K. Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene. J Biol Chem 272 1 (1997) 556-562
15. Porter S., Clark I.M., Kevorkian L., and Edwards D.R. The ADAMTS metalloproteinases. Biochem J 386 Pt 1 (2005) 15-27
16. Blobel C.P., Wolfsberg T.G., Turck C.W., Myles D.G., Primakoff P., and White J.M. A potential fusion peptide and an integrin ligand domain in a protein active in sperm-egg fusion. Nature 356 6366 (1992) 248-252
17. Cho C., Bunch D.O., Faure J.E., Goulding E.H., Eddy E.M., Primakoff P., et al. Fertilization defects in sperm from mice lacking fertilin beta. Science 281 5384 (1998) 1857-1859
18. Zolkiewska A. Disintegrin-like/cysteine-rich region of ADAM 12 is an active cell adhesion domain. Exp Cell Res 252 2 (1999) 423-431
19. Gaultier A., Cousin H., Darribere T., and Alfandari D. ADAM13 disintegrin and cysteine-rich domains bind to the second heparin-binding domain of fibronectin. J Biol Chem 277 26 (2002) 23336-23344
20. Iba K., Albrechtsen R., Gilpin B., Frohlich C., Loechel F., Zolkiewska A., et al. The cysteine-rich domain of human ADAM 12 supports cell adhesion through syndecans and triggers signaling events that lead to beta1 integrin-dependent cell spreading. J Cell Biol 149 5 (2000) 1143-1156
21. Zigrino P., Steiger J., Fox J.W., Loffek S., Schild A., Nischt R., et al. Role of ADAM-9 disintegrin-cysteine-rich domains in human keratinocyte migration. J Biol Chem 282 42 (2007) 30785-30793
22. Reddy P., Slack J.L., Davis R., Cerretti D.P., Kozlosky C.J., Blanton R.A., et al. Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme. J Biol Chem 275 19 (2000) 14608-14614
23. Smith K.M., Gaultier A., Cousin H., Alfandari D., White J.M., and DeSimone D.W. The cysteine-rich domain regulates ADAM protease function in vivo. J Cell Biol 159 5 (2002) 893-902
24. Takeda S., Igarashi T., Mori H., and Araki S. Crystal structures of VAP1 reveal ADAMs' MDC domain architecture and its unique C-shaped scaffold. EMBO J 25 11 (2006) 2388-2396
25. Igarashi T., Araki S., Mori H., and Takeda S. Crystal structures of catrocollastatin/VAP2B reveal a dynamic, modular architecture of ADAM/adamalysin/reprolysin family proteins. FEBS Lett 581 13 (2007) 2416-2422
26. Takeda S., Igarashi T., and Mori H. Crystal structure of RVV-X: an example of evolutionary gain of specificity by ADAM proteinases. FEBS Lett 581 30 (2007) 5859-5864
27. Janes P.W., Saha N., Barton W.A., Kolev M.V., Wimmer-Kleikamp S.H., Nievergall E., et al. Adam Meets Eph: an ADAM substrate recognition module acts as a molecular switch for Ephrin cleavage in trans. Cell 123 2 (2005) 291-304
28. Gerhardt S., Hassall G., Hawtin P., McCall E., Flavell L., Minshull C., et al. Crystal structures of human ADAMTS-1 reveal a conserved catalytic domain and a disintegrin-like domain with a fold homologous to cysteine-rich domains. J Mol Biol 373 4 (2007) 891-902
29. Mosyak L., Georgiadis K., Shane T., Svenson K., Hebert T., McDonagh T., et al. Crystal structures of the two major aggrecan degrading enzymes, ADAMTS4 and ADAMTS5. Protein Sci 17 1 (2008) 16-21
30. Fox J.W., and Serrano S.M. Structural considerations of the snake venom metalloproteinases, key members of the M12 reprolysin family of metalloproteinases. Toxicon 45 8 (2005) 969-985
31. Takeda S. VAP1: snake venom homolog of mammalian ADAMs. In: Messerschmidt A (Ed.). Handbook of Metalloproteins. John Wiley & Sons, Inc.; 2008, doi:10.1002/0470028637.met234.
32. Maskos K., Fernandez-Catalan C., Huber R., Bourenkov G.P., Bartunik H., Ellestad G.A., et al. Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme. Proc Natl Acad Sci U S A 95 7 (1998) 3408-3412
33. Orth P., Reichert P., Wang W., Prosise W.W., Yarosh-Tomaine T., Hammond G., et al. Crystal structure of the catalytic domain of human ADAM33. J Mol Biol 335 1 (2004) 129-137
34. Shieh H.S., Mathis K.J., Williams J.M., Hills R.L., Wiese J.F., Benson T.E., et al. High resolution crystal structure of the catalytic domain of ADAMTS-5 (aggrecanase-2). J Biol Chem (2007)
35. Gomis-Ruth F.X., Kress L.F., and Bode W. First structure of a snake venom metalloproteinase: a prototype for matrix metalloproteinases/collagenases. EMBO J 12 11 (1993) 4151-4157
36. Arribas J., and Ruiz-Paz S. ADAM17: Regulation of ectodomain shedding. In: Hooper N.M., and Lendeckel U. (Eds). The ADAM Family of Proteinases (2005), Springer, Dordrecht, The Netherlands 171-197
37. Gould R.J., Polokoff M.A., Friedman P.A., Huang T.F., Holt J.C., Cook J.J., et al. Disintegrins: a family of integrin inhibitory proteins from viper venoms. Proc Soc Exp Biol Med 195 2 (1990) 168-171
38. Calvete J.J., Marcinkiewicz C., Monleon D., Esteve V., Celda B., Juarez P., et al. Snake venom disintegrins: evolution of structure and function. Toxicon 45 8 (2005) 1063-1074
39. Lu X., Lu D., Scully M.F., and Kakkar V.V. Structure-activity relationship studies on ADAM protein-integrin interactions. Cardiovasc Hematol Agents Med Chem 5 1 (2007) 29-42
40. Takagi J. Structural basis for ligand recognition by integrins. Curr Opin Cell Biol 19 5 (2007) 557-564
41. Fujii Y., Okuda D., Fujimoto Z., Horii K., Morita T., and Mizuno H. Crystal structure of trimestatin, a disintegrin containing a cell adhesion recognition motif RGD. J Mol Biol 332 5 (2003) 1115-1122
42. Eto K., Huet C., Tarui T., Kupriyanov S., Liu H.Z., Puzon-McLaughlin W., et al. Functional classification of ADAMs based on a conserved motif for binding to integrin alpha 9beta 1: implications for sperm-egg binding and other cell interactions. J Biol Chem 277 20 (2002) 17804-17810
43. Gao W., Anderson P.J., and Sadler J.E. Extensive contacts between ADAMTS13 exosites and von Willebrand factor domain A2 contribute to substrate specificity. Blood (2008)
44. Alfandari D., Cousin H., Gaultier A., Smith K., White J.M., Darribere T., et al. Xenopus ADAM 13 is a metalloprotease required for cranial neural crest-cell migration. Curr Biol 11 12 (2001) 918-930
45. Usami Y., Fujimura Y., Miura S., Shima H., Yoshida E., Yoshioka A., et al. A 28 kDa-protein with disintegrin-like structure (jararhagin-C) purified from Bothrops jararaca venom inhibits collagen- and ADP-induced platelet aggregation. Biochem Biophys Res Commun 201 1 (1994) 331-339
46. Shimokawa K., Shannon J.D., Jia L.G., and Fox J.W. Sequence and biological activity of catrocollastatin-C: a disintegrin-like/cysteine-rich two-domain protein from Crotalus atrox venom. Arch Biochem Biophys 343 1 (1997) 35-43
47. Jia L.G., Wang X.M., Shannon J.D., Bjarnason J.B., and Fox J.W. Inhibition of platelet aggregation by the recombinant cysteine-rich domain of the hemorrhagic snake venom metalloproteinase, atrolysin A. Arch Biochem Biophys 373 1 (2000) 281-286
48. Serrano S.M., Jia L.G., Wang D., Shannon J.D., and Fox J.W. Function of the cysteine-rich domain of the haemorrhagic metalloproteinase atrolysin A: targeting adhesion proteins collagen I and von Willebrand factor. Biochem J 391 Pt 1 (2005) 69-76
49. Serrano S.M., Wang D., Shannon J.D., Pinto A.F., Polanowska-Grabowska R.K., and Fox J.W. Interaction of the cysteine-rich domain of snake venom metalloproteinases with the A1 domain of von Willebrand factor promotes site-specific proteolysis of von Willebrand factor and inhibition of von Willebrand factor-mediated platelet aggregation. FEBS J 274 14 (2007) 3611-3621
50. Serrano S.M., Kim J., Wang D., Dragulev B., Shannon J.D., Mann H.H., et al. The cysteine-rich domain of snake venom metalloproteinases is a ligand for von Willebrand factor A domains: role in substrate targeting. J Biol Chem 281 52 (2006) 39746-39756
51. Pinto A.F., Terra R.M., Guimaraes J.A., and Fox J.W. Mapping von Willebrand factor A domain binding sites on a snake venom metalloproteinase cysteine-rich domain. Arch Biochem Biophys 457 1 (2007) 41-46
52. Kamiguti A.S., Gallagher P., Marcinkiewicz C., Theakston R.D., Zuzel M., and Fox J.W. Identification of sites in the cysteine-rich domain of the class P-III snake venom metalloproteinases responsible for inhibition of platelet function. FEBS Lett 549 1-3 (2003) 129-134
53. Morita T. Structures and functions of snake venom CLPs (C-type lectin-like proteins) with anticoagulant-, procoagulant-, and platelet-modulating activities. Toxicon 45 8 (2005) 1099-1114